Published: 5/10/2022 9:30:01 PM

Execution will be key - SEB

We leave our estimates broadly unchanged after the Q1 results, which were in line with pre-announced figures. In our view, the preconditions for strong growth are in place, but strong execution and sustained delivery of the company’s high growth ambitions are likely needed to reignite the equity story following the Q1 setback. Our DCF-based fair value range remains unchanged at SEK 31-40 per share.

Link to the analysis

Read more about SyntheticMR AB